Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond the 5-HT2AReceptor: Classic and Nonclassic Targets in Psychedelic Drug Action
Lindsay P. Cameron, Joseph Benetatos, Vern Lewis, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 45, pp. 7472-7482
Open Access | Times Cited: 21

Showing 21 citing articles:

Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
The role of serotonin in depression—A historical roundup and future directions
Svenja Bremshey, Juliana Groß, Kim Renken, et al.
Journal of Neurochemistry (2024)
Open Access | Times Cited: 15
1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review
Richard A. Glennon, Małgorzata Dukat
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 6, pp. 1722-1745
Open Access | Times Cited: 10
Impact of psilocybin on cognitive function: A systematic review
Shakila Meshkat, Triana Juliana Tello‐Gerez, Fatemeh Gholaminezhad, et al.
Psychiatry and Clinical Neurosciences (2024) Vol. 78, Iss. 12, pp. 744-764
Open Access | Times Cited: 5
Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats
Zitong Wang, Brett Robbins, R. L. Zhuang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111243-111243
Open Access
Toluene Toxicity in the Brain: From Cellular Targets to Molecular Mechanisms
Andrew Shaw, Jeffery D. Steketee, Anna N. Bukiya, et al.
The Annual Review of Pharmacology and Toxicology (2025) Vol. 65, Iss. 1, pp. 487-506
Closed Access
Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
Daniel A Kinderlehrer
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 141-155
Open Access
Phenethylaminylation: Preliminary In Vitro Evidence for the Covalent Transamidation of Psychedelic Phenethylamines to Glial Proteins using 3,5-Dimethoxy-4-(2-Propynyloxy)-Phenethylamine as a Model Compound
Rajiv Rangan, Russell Petty, Suchismita Acharya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Chronobiological and Neuroprotective Mechanisms of Resveratrol in Improving Sleep
Wenwen Zhu, Aihua Gong, Bin Zhang, et al.
Mediators of Inflammation (2025) Vol. 2025, Iss. 1
Open Access
Mucuna pruriens to treat Parkinson's disease in low-income countries: Recommendations and practical guidelines from the farmer to clinical trials. Paving the way for future use in clinical practice
Serena Caronni, Francesca Del Sorbo, Michela Barichella, et al.
Parkinsonism & Related Disorders (2024) Vol. 124, pp. 106983-106983
Closed Access | Times Cited: 4
Serotonergic neuromodulation of synaptic plasticity
Guilherme Shigueto Vilar Higa, Felipe José Costa Viana, José Fernando de Oliveira, et al.
Neuropharmacology (2024) Vol. 257, pp. 110036-110036
Closed Access | Times Cited: 3
Distinct 5-HT receptor subtypes regulate claustrum excitability by serotonin and the psychedelic, DOI
Tanner L. Anderson, Jack Keady, Judy C. Songrady, et al.
Progress in Neurobiology (2024) Vol. 240, pp. 102660-102660
Closed Access | Times Cited: 3
Rethinking the role of TRKB in the action of antidepressants and psychedelics
Cecilia A. Brunello, Cecilia Cannarozzo, Eero Ċastrén
Trends in Neurosciences (2024)
Open Access | Times Cited: 3
Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents
Isabel Werle, Leandro J. Bertoglio
Neuroscience & Biobehavioral Reviews (2024), pp. 105899-105899
Closed Access | Times Cited: 1
Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
Laith Alexander, David J. Anderson, Luke Baxter, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
The selective 5-HT2Areceptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents
Anders A. Jensen, Cláudia R. Cecchi, Meghan Hibicke, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.
Daniël Hoyer
Authorea (Authorea) (2024)
Open Access
Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice
Veronika Pohořalá, Martin Kuchař, Rainer Spanagel, et al.
Neuroscience (2024) Vol. 559, pp. 156-165
Closed Access
Serotonin circuits act cooperatively with pathophysiology of opioid use disorder
Hiroyuki Arakawa, Ozawa Akihiko
Addiction Neuroscience (2024), pp. 100187-100187
Open Access
The potential of non-psychedelic 5-HT2A agents in the treatment of substance use disorders: a narrative review of the clinical literature
Alejandra Pulido-Saavedra, A Borelli, Razi Kitaneh, et al.
Expert Opinion on Pharmacotherapy (2024), pp. 1-14
Closed Access
Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023)
Closed Access
Page 1

Scroll to top